As I prepare to leave the land of Rembrandt, Van Gogh, canals, windmills, tulips, wooden shoes – and for the last five days the global hub for all things cardiology – I can’t help but feel proud of our profession and the continued strides were are making to improve the cardiovascular health of the global population. Continue reading
Alfred Bove, MD, PhD, MACC, and Deepak Bhatt, MD, MPH, FACC, discuss the PURE-Sodium Trial, TASTE (RRCT) Trial, and AMADEUS Trial.
Spencer B. King III, MD, MACC, and Alfred Bove, MD, PhD, MACC, discuss the ATOMIC-AHF Trial, MADIT-CRT LIFR Trial, EchoCRT Trial, Tour de France Trial, and CHAMPION Trial.
This post was authored by Patrick T. O’Gara, MD, FACC, ACC president-elect.
What role will the ACC play in public and population health? How can we help cardiovascular professionals around the globe efficiently and demonstrably achieve and maintain the highest levels of patient care? These were some of the questions that the ACC’s Assembly of International Governors (AIG) came together to tackle while attending the ESC Congress 2013 in Amsterdam this week. Continue reading
Spencer King, MD, MACC and Ben Scirica, MD, FACC discuss the TASTE Trial, TAO Trial, PARIS Trial, Hokusai VTE Trial, RE-ALIGN Trial, and Everyday Lifestyle study.
Christopher Cannon, MD, FACC, editor in chief of CardioSource Science and Quality, and Deepak Bhatt, MD, FACC, associate editor of CardioSource clinical trials, provide a preview of topics that will be presented at the European Society of Cardiology (ESC) Congress 2013 in Amsterdam from Aug. 31 – Sept. 4. Continue reading